Menu Search
Equities

C-Mer Medical Holdings Ltd

3309:HKG.HZ

C-Mer Medical Holdings Ltd

Actions
  • Price (HKD)2.55
  • Today's Change0.04 / 1.59%
  • Shares traded148.00k
  • 1 Year change-34.95%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

C-Mer Medical Holdings Ltd, formerly C-Mer Eye Care Holdings Ltd, is an investment holding company mainly engaged in the medical services business. The Company operates its business through four segments. The HK Medical Business segment is mainly engaged in the provision of ophthalmic, dental and other medical services and sales of vision aid products in Hong Kong. The Mainland China Dental Business segment is mainly engaged in the provision of dental services in Mainland China. The Sales of Medical Consumables segment is mainly engaged in the sales of medical consumables in Hong Kong business. The Mainland China Ophthalmic Business segment is mainly engaged in the provision of ophthalmic services and sales of vision aid products in Mainland China.

  • Revenue in HKD (TTM)1.92bn
  • Net income in HKD62.00m
  • Incorporated2016
  • Employees3.27k
  • Location
    C-Mer Medical Holdings LtdSuite 1515, Central Building1-3 Pedder Street, Central Hong KongHKG
  • Phone+852 39973266
  • Fax+852 39968212
  • Websitehttps://www.cmermedical.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.